The Gibco LV-MAX Lentiviral Production System is the first optimized system that provides a scalable and high-yield lentiviral vector (LVV) production platform
Binding Site’s Immunologicals Group is pleased to announce the addition of eight new recombinant antigens to its broad offering of products for in-vitro diagnostic (IVD) manufacturing and research applications
Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research
The new assay runs on the company’s LIAISON® MDX qPCR system, a scalable benchtop instrument that delivers qualitative and quantitative, sample-to-answer, multi-analyte results